Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee

NCT04120402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: EP-104IAR 25 mg
DRUG: Vehicle

Sponsor

Eupraxia Pharmaceuticals Inc.

Collaborators

[object Object]